Latest News
Gilead Announces Data from Study of Ranexa® in Chronic Angina Patients with Type 2 Diabetes at ACC’s Annual Scientific Session |
![]() |
News
- Read Gilead's 2011 Annual Report
- Gilead ’s Ranexa® Reduces Angina Frequency in Study of Chronic Angina Patients With Type 2 Diabetes
- Gilead Announces Full 24-Week Phase 2 Results for Once-Daily Single Tablet HIV Regimen Containing Novel Prodrug Tenofovir Alafenamide (TAF)
- Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
- View all news
Events
- April 6 - 10, 2013
American Association for Cancer Research Annual Meeting
Washington, DC - April 24 - 28, 2013
48th Annual Meeting of the European Association for the Study of the Liver
Amsterdam, the Netherlands - May 14 - 16, 2013
Bank of America Merrill Lynch 2013 Health Care Conference
Las Vegas, NV - View all events